Williamson Deborah A, Lim Alwin, Wiles Siouxsie, Roberts Sally A, Freeman Joshua T
Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
BMC Infect Dis. 2013 Aug 21;13:385. doi: 10.1186/1471-2334-13-385.
Escherichia coli is a major human pathogen, both in community and healthcare settings. To date however, relatively few studies have defined the population burden of E. coli bloodstream infections. Such information is important in informing strategies around treatment and prevention of these serious infections. Against this background, we performed a retrospective, population-based observational study of all cases of E. coli bacteremia in patients presenting to our hospital between January 2005 and December 2011.
Auckland District Health Board is a tertiary-level, university-affiliated institution serving a population of approximately 500,000, within a larger metropolitan population of 1.4 million. We identified all patients with an episode of bloodstream infection due to E. coli over the study period. A unique episode was defined as the first positive E. coli blood culture taken from the same patient within a thirty-day period. Standard definitions were used to classify episodes into community- or healthcare-associated E. coli bacteremia. Demographic information was obtained for all patients, including: age; gender; ethnicity; length of stay (days); requirement for intensive care admission and all-cause, in-patient mortality.
A total of 1507 patients had a unique episode of E. coli bacteremia over the study period. The overall average annual incidence of E. coli bacteremia was 52 per 100,000 population, and was highest in the under one year and over 65-year age groups. When stratified by ethnicity, rates were highest in Pacific Peoples and Māori (83 and 62 per 100,000 population respectively). The incidence of community-onset E. coli bacteremia increased significantly over the study period. The overall in-hospital mortality rate was 9% (135/1507), and was significantly higher in patients who had a hospital-onset E. coli bacteremia.
Our work provides valuable baseline data on the incidence of E. coli bacteremia in our locale. The incidence was higher that that described from other developed countries, with significant demographic variation, most notably in ethnic-specific incidence rates. Future work should assess the possible reasons for this disparity.
大肠杆菌是社区和医疗机构中主要的人类病原体。然而,迄今为止,相对较少的研究确定了大肠杆菌血流感染的人群负担。此类信息对于制定针对这些严重感染的治疗和预防策略至关重要。在此背景下,我们对2005年1月至2011年12月期间到我院就诊的所有大肠杆菌菌血症病例进行了一项基于人群的回顾性观察研究。
奥克兰地区卫生局是一家三级大学附属医院,服务人口约50万,所在大都市人口为140万。我们确定了研究期间所有因大肠杆菌导致血流感染的患者。一次独特的感染发作定义为在30天内从同一患者采集的首次阳性大肠杆菌血培养。采用标准定义将感染发作分为社区相关性或医疗机构相关性大肠杆菌菌血症。获取了所有患者的人口统计学信息,包括:年龄;性别;种族;住院时间(天);重症监护病房入住需求以及全因住院死亡率。
在研究期间,共有1507例患者发生了独特的大肠杆菌菌血症发作。大肠杆菌菌血症的总体年平均发病率为每10万人52例,在1岁以下和65岁以上年龄组中最高。按种族分层时,太平洋岛民和毛利人的发病率最高(分别为每10万人83例和62例)。在研究期间,社区起病的大肠杆菌菌血症发病率显著增加。总体住院死亡率为9%(135/1507),在医院起病的大肠杆菌菌血症患者中显著更高。
我们的工作提供了关于我们地区大肠杆菌菌血症发病率的宝贵基线数据。该发病率高于其他发达国家描述的发病率,存在显著的人口统计学差异,最明显的是在特定种族发病率方面。未来的工作应评估这种差异的可能原因。